Johnson & Johnson (JNJ) vs Walmart Inc. (WMT)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Founded in 1962, Walmart Inc. has grown into the world’s largest retailer, operating more than 10,700 stores worldwide, including about 4,600 Walmart locations in the United States and roughly 600 Sam’s Club warehouses, while continuing to expand its e-commerce business. The company serves around 270 million customers each week and generated over $680 billion in fiscal 2025 revenue. Walmart’s operations are organized into three reporting segments: Walmart U.S., which accounted for 68% of fiscal 2025 sales, Walmart International at 18%, and Sam’s Club at 14%. In the U.S., nearly 60% of Walmart’s $465 billion in fiscal 2025 revenue came from grocery sales, with about one-quarter generated by general merchandise. Internationally, the company’s business is primarily concentrated in Mexico, with additional emerging exposure to India.